Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03608150 · ClinicalTrials.gov registry record · NA
Luminopia One Amblyopia Vision Improvement Study
A NA study, sponsored by Luminopia.
- Completed
- Registry status
- NA
- Development phase
- 117
- Enrollment target
NCT03608150: Completed NA study, sponsored by Luminopia.
NCT03608150 is a NA study that has completed, run by Luminopia. The registered enrollment target is 117 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03608150, a NA study, has completed, sponsored by Luminopia.
- COMPLETED
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
Study Summary
The objective of the study is to demonstrate the safety and efficacy of Luminopia One in amblyopia patients with amblyopia associated with anisometropia and/or with mild strabismus.
Primary Outcome
Mean improvement in best-corrected visual acuity of amblyopic eye from baseline after 12 weeks of treatment using electronic ATS-HOTV protocol.
Interventions
- DEVICE Luminopia One
- DEVICE Refractive Correction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2019-01-16 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
What the finished NCT03608150 record still lists
NCT03608150 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Luminopia One is the first listed.
NCT03608150 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03608150 about?
NCT03608150 is a clinical study titled "Luminopia One Amblyopia Vision Improvement Study". The objective of the study is to demonstrate the safety and efficacy of Luminopia One in amblyopia patients with amblyopia associated with anisometropia and/or with mild strabismus.
What is the current status of trial NCT03608150?
This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2019-01-16. Estimated completion is 2020-07-31.
What interventions are being tested in trial NCT03608150?
The interventions under investigation include: Luminopia One (DEVICE), Refractive Correction (DEVICE).
Who is sponsoring clinical trial NCT03608150?
This trial is sponsored by Luminopia, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03608150's enrollment target sits among peer trials
117 807th of 2000 higher than 1,193 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI